Research
Hormonal
Broad access to semaglutide would result in 38,950 cardiovascular events avoided and 6,180 deaths avoided over a 10-year period.
Practitioners should consider the significant health benefits of prescribing semaglutide to eligible Medicare patients.
StrongSupportsmedium confidence
Over the 10-year period, we estimated that broad access to semaglutide would result in 38 950 cardiovascular events avoided, and 6180 deaths avoided due to reduction in cardiovascular events and improvement in chronic kidney disease or metabolic-associated steatohepatitis progression.
Why this rating
The study uses data from government reports, clinical studies, and real-world claims, indicating a robust methodology.
Source
Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare
Victoria Dayer et al. · Value in Health · 2025
otherCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →